CCChris Coulter

Chris Coulter

*This is an algorithmically generated author record based on publicly available information.

Chris Coulter has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Robyn Carter

    Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Royal Brisbane and Women’s Hospital Herston, Herston, QLD 4029, Australia

    3 shared publications
  • Alex R. Hoffmaster

    Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4018, USA

    1 shared publication
  • Amy V. Jennison

    Public and Environmental Health, Pathology Queensland, Queensland Health, Brisbane, Australia

    1 shared publication
  • Barun K. De

    Centers for Disease Control and Prevention, Atlanta, Georgia, USA

    1 shared publication
  • Beverlyn Warigi

    Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province 441, Papua New Guinea

    1 shared publication
  • Carla Tolson

    QLD Mycobacterial Reference Laboratory, Pathology Queensland, RBWH Campus, Herston Rd, Herston, QLD 4006, Australia

    1 shared publication

Latest Publications

  • Open Access

    TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study

    by Gail B Cross, Katie Coles, Mandana Nikpour, Owen A Moore, Justin Denholm, Emma S McBryde, Damon P Eisen, Beverlyn Warigi, Robyn Carter, Sushil Pandey, et al.

    The incidence and characteristics of tuberculosis (TB) in remote areas of Papua New Guinea (PNG) are largely unknown. The purpose of our study was to determine the incidence of TB in the Gulf Province of PNG and describe disease characteristics, co-morbidities and drug resistance profiles that could impact on disease outcomes and transmission.


  • Open Access

    Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia

    by Rachel M Thomson, Robyn Carter, Carla Tolson, Chris Coulter, Flavia Huygens, Megan Hargreaves

    Nontuberculous mycobacteria (NTM) are normal inhabitants of a variety of environmental reservoirs including natural and municipal water. The aim of this study was to document the variety of species of NTM in potable water in Brisbane, QLD, with a specific interest in the main pathogens responsible for disease in this region and to explore factors associated with the isolation of NTM. One-litre water samples were collected from 189 routine collection sites in summer and 195 sites in winter. Samples were split, with half decontaminated with CPC 0.005%, then concentrated by filtration and cultured on 7H11 plates in MGIT tubes (winter only).


  • Open Access

    Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea

    by Marie Ballif, Paul Harino, Serej Ley, Mireia Coscolla, Stefan Niemann, Robyn Carter, Christopher Coulter, Sonia Borrell, Peter Siba, Suparat Phuanukoonnon, et al.

    Background: Monitoring drug resistance in Mycobacterium tuberculosis is essential to curb the spread of tuberculosis (TB). Unfortunately, drug susceptibility testing is currently not available in Papua New Guinea (PNG) and that impairs TB control in this country. We report for the first time M. tuberculosis mutations associated with resistance to first and second-line anti-TB drugs in Madang, PNG. A molecular cluster analysis was performed to identify M. tuberculosis transmission in that region. Results: Phenotypic drug susceptibility tests showed 15.7% resistance to at least one drug and 5.2% multidrug resistant (MDR) TB. Rifampicin resistant strains had the rpoB mutations D516F, D516Y or S531L; Isoniazid resistant strains had the mutations katG S315T or inhA promoter C15T; Streptomycin resistant strains had the mutations rpsL K43R, K88Q, K88R), rrs A514C or gidB V77G. The molecular cluster analysis indicated evidence for transmission of resistant strain. Conclusions: We observed a substantial rate of MDR-TB in the Madang area of PNG associated with mutations in specific genes. A close monitoring of drug resistance is therefore urgently required, particularly in the presence of drug-resistant M. tuberculosis transmission. In the absence of phenotypic drug susceptibility testing in PNG, molecular assays for drug resistance monitoring would be of advantage.


    • 1 July 2012
      • Vol. 41  (7) , 489-92

    Tuberculosis testing.

    by Chris Coulter

    This article forms part of our 'Tests and results' series for 2012, which aims to provide information about common tests that general practitioners order regularly. It considers areas such as indications, what to tell the patient, what the test can and cannot tell you, and interpretation of results.


  • Open Access

    Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia

    by Rebekah V Tiller, Jay E Gee, David R Lonsway, Sonali Gribble, Scott C Bell, Amy V Jennison, John Bates, Chris Coulter, Alex R Hoffmaster, Barun K De

    Background: Brucellosis is primarily a zoonotic disease caused by Brucella species. There are currently ten Brucella spp. including the recently identified novel B. inopinata sp. isolated from a wound associated with a breast implant infection. In this study we report on the identification of an unusual Brucella-like strain (BO2) isolated from a lung biopsy in a 52-year-old patient in Australia with a clinical history of chronic destructive pneumonia. Results: Standard biochemical profiles confirmed that the unusual strain was a member of the Brucella genus and the full-length 16S rRNA gene sequence was 100% identical to the recently identified B. inopinata sp. nov. (type strain BO1T). Additional sequence analysis of the recA, omp2a and 2b genes; and multiple locus sequence analysis (MLSA) demonstrated that strain BO2 exhibited significant similarity to the B. inopinata sp. compared to any of the other Brucella or Ochrobactrum species. Genotyping based on multiple-locus variable-number tandem repeat analysis (MLVA) established that the BO2 and BO1Tstrains form a distinct phylogenetic cluster separate from the other Brucella spp. Conclusion: Based on these molecular and microbiological characterizations, we propose that the BO2 strain is a novel lineage of the newly described B. inopinata species.


  • Open Access

    Skin and soft tissue infections due to non-tuberculous mycobacteria

    by Chris Coulter, Jenny Robson

    The non-tuberculous mycobacteria (NTM) are composed of species other than Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis including BCG, M. microti, M. africanum) and M. leprae. NTM are a diverse and growing group of more than 100 species that occupy a wide variety of environmental niches throughout the world, being particularly common in soil and water. For several species, survival in biofilms facilitates their presence in water distribution systems.